首页|乌头碱调控miR-150-5p表达对心力衰竭模型大鼠心功能及心室重构的影响

乌头碱调控miR-150-5p表达对心力衰竭模型大鼠心功能及心室重构的影响

Effect of aconitine on cardiac function and ventricular remodeling in heart failure model rats by regulating miR-150-5p expression

扫码查看
目的 探究乌头碱对心力衰竭模型大鼠心功能及心室重构的影响及对miR-150-5p的调控作用.方法 将SPF级SD雄性大鼠随机分为假手术组、模型组、曲美他嗪组、乌头碱组、乌头碱+antagomir-NC 组、乌头碱+miR-150-5p antagomir组,每组 15 只.除假手术组外,其余组均利用结扎左前降支冠状动脉法建立心力衰竭大鼠模型.测定各组大鼠心功能指标左室舒张末期内径(LVEDD)、左室收缩末期内径(LVESD)、左室射血分数(LVEF);ELISA 检测各组大鼠心肌损伤指标心肌肌钙蛋白I(CTnI)、脑钠肽(BNP)和N末端B型脑钠肽前体(NT-proBNP)的水平;测定各组大鼠心脏和左心室质量指数;Masson染色观察各组大鼠心肌组织形态;TUNEL染色检测各组大鼠心肌细胞凋亡率;RT-qRCR检测各组大鼠心肌组织中miR-150-5p和细胞周期蛋白D2(CCND2)的表达;双荧光素酶报告基因实验验证miR-150-5p与CCND2的靶向关系;Western blotting检测心肌细胞中CCND2 蛋白的表达.结果 与模型组相比,乌头碱组大鼠心功能指标LVEDD、LVESD、心肌损伤指标CTnI、BNP和NT-proBNP水平、心脏质量指数、左心室质量指数、心肌纤维化区域、心肌细胞凋亡率和CCND2 mRNA水平均降低(P<0.05),LVEF、miR-150-5p水平升高(P<0.05);使用miR-150-5p antagomir进行回补实验,结果显示,乌头碱对心力衰竭大鼠心功能和心室重构的保护作用被逆转,且CCND2 mRNA 水平升高(P<0.05);与 miR-150-5p mimic-NC组相比,miR-150-5p mimic组心肌细胞CCND2 蛋白表达显著降低(P<0.05),且双荧光素酶报告基因实验验证了miR-150-5p与CCND2 之间存在靶向关系.结论 乌头碱通过上调miR-150-5p表达对心力衰竭大鼠心功能和心室重构发挥保护作用.
Objective To investigate the impacts of aconitine on cardiac function and ventricular remodeling in heart failure model rats,and its regulatory effect on miR-150-5p during this process.Methods SPF grade SD male rats were randomly grouped into sham surgery group,model group,trimetazidine group,aconitine group,aconitine + antagonimir NC group,and aconitine + miR-150-5p antagonimir group,with 15 rats in each group.Except for the sham surgery group,all other groups established heart failure rat models by ligating the left anterior descending coronary artery.The left ventricular end diastolic diameter(LVEDD),left ventricular end systolic diameter(LVESD),and left ventricular ejection fraction(LVEF)were measured for cardiac function indicators of rats in each group.ELISA was applied to detect the levels of myocardial injury indicators cardiac troponin I(CTnI),brain natriuretic peptide(BNP),and N-terminal B-type brain natriuretic peptide precursor(NT-proBNP)of rats in each group.Heart and left ventricular mass index of rats in each group were measured.Masson staining was applied to observe the myocardial tissue morphology of rats in each group,TUNEL staining was applied to detect the apoptosis rate of myocardial cells of rats in each group.RT-qRCR was applied to detect the expression of miR-150-5p and cyclin D2(CCND2)in myocardial tissue of rats in each group.The double luciferase reporter gene experiment verified the targeting relationship between miR-150-5p and CCND2.Western blotting was used to detect the expression of CCND2 protein in myocardial cells.Results Compared with the model group,the cardiac function indicators LVEDD,LVESD,myocardial injury indicators CTnI,BNP,and NT proBNP levels,cardiac mass index,left ventricular mass index,myocardial fibrosis area,myocardial cell apoptosis rate and the level of CCND2 mRNA in the aconitine group decreased(P<0.05).The levels of LVEF and miR-150-5p increased(P<0.05).Supplementation experiments with miR-150-5p antagomir showed that the protective effects of aconitine on cardiac function and ventricular remodeling in rats with heart failure were reversed,and CCND2 mRNA levels were increased(P<0.05).Compared with miR-150-5p mimic-NC group,the expression of CCND2 protein in myocardial cells in miR-150-5p mimic group was significantly decreased(P<0.05),and the double luciferase reporter gene experiment verified that there was a targeted relationship between miR-150-5p and CCND2.Conclusion Aconitine plays a protective role in cardiac function and ventricular remodeling in rats with heart failure by up-regulating the expression of miR-150-5p.

aconitineheart failuremiR-150-5pcardiac functionventricular remodelingCCND2

赵彩霞、刘爽、刘文秀、岳华、庞鑫鑫、马玉昕

展开 >

中国人民解放军联勤保障部队第九八〇医院 医疗保障中心 药剂科,河北 石家庄 050000

中国人民解放军联勤保障部队第九八〇医院 病理科,河北 石家庄 050000

中国人民解放军联勤保障部队第九八〇医院 心血管内科,河北 石家庄 050000

中国人民解放军联勤保障部队第九八〇医院 临床药学科,河北 石家庄 050000

中国人民解放军联勤保障部队第九八〇医院 皮肤科,河北 石家庄 050000

展开 >

乌头碱 心力衰竭 miR-150-5p 心功能 心室重构 细胞周期蛋白D2

河北省中医药局科研项目

2022442

2024

现代药物与临床
天津药物研究院,中国药学会

现代药物与临床

CSTPCD
影响因子:1.179
ISSN:1674-5515
年,卷(期):2024.39(5)
  • 22